The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry
出版年份 2015 全文链接
标题
The Interferon-induced Transmembrane Proteins, IFITM1, IFITM2, and IFITM3 Inhibit Hepatitis C Virus Entry
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 290, Issue 43, Pages 25946-25959
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2015-09-10
DOI
10.1074/jbc.m115.657346
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Identification of an endocytic signal essential for the antiviral action of IFITM3
- (2014) Rui Jia et al. CELLULAR MICROBIOLOGY
- Phosphorylation of the Antiviral Protein Interferon-inducible Transmembrane Protein 3 (IFITM3) Dually Regulates Its Endocytosis and Ubiquitination
- (2014) Nicholas M. Chesarino et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Virology and cell biology of the hepatitis C virus life cycle – An update
- (2014) Jean Dubuisson et al. JOURNAL OF HEPATOLOGY
- Dynamic Imaging of the Hepatitis C Virus NS5A Protein during a Productive Infection
- (2014) N. S. Eyre et al. JOURNAL OF VIROLOGY
- Integrative Functional Genomics of Hepatitis C Virus Infection Identifies Host Dependencies in Complete Viral Replication Cycle
- (2014) Qisheng Li et al. PLoS Pathogens
- IFITM3 Restricts Influenza A Virus Entry by Blocking the Formation of Fusion Pores following Virus-Endosome Hemifusion
- (2014) Tanay M. Desai et al. PLoS Pathogens
- IFITM-Family Proteins: The Cell's First Line of Antiviral Defense
- (2014) Charles C. Bailey et al. Annual Review of Virology
- The Antiviral Effector IFITM3 Disrupts Intracellular Cholesterol Homeostasis to Block Viral Entry
- (2013) Samad Amini-Bavil-Olyaee et al. Cell Host & Microbe
- What does S-palmitoylation do to membrane proteins?
- (2013) Sanja Blaskovic et al. FEBS Journal
- Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus
- (2013) Erin M. McCartney et al. HEPATOLOGY
- The CD225 Domain of IFITM3 Is Required for both IFITM Protein Association and Inhibition of Influenza A Virus and Dengue Virus Replication
- (2013) S. P. John et al. JOURNAL OF VIROLOGY
- Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins
- (2013) Nopporn Chutiwitoonchai et al. MICROBES AND INFECTION
- Global control of hepatitis C: where challenge meets opportunity
- (2013) David L Thomas NATURE MEDICINE
- IFITM Proteins Restrict Viral Membrane Hemifusion
- (2013) Kun Li et al. PLoS Pathogens
- Antiviral resistance and direct-acting antiviral agents for HCV
- (2012) Amanda L Aloia et al. ANTIVIRAL THERAPY
- Evolution of vertebrate interferon inducible transmembrane proteins
- (2012) Danielle Hickford et al. BMC GENOMICS
- IFITM1 is a tight junction protein that inhibits hepatitis C virus entry
- (2012) Courtney Wilkins et al. HEPATOLOGY
- S-Palmitoylation and Ubiquitination Differentially Regulate Interferon-induced Transmembrane Protein 3 (IFITM3)-mediated Resistance to Influenza Virus
- (2012) Jacob S. Yount et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hepatitis C Virus Infection Modulates Expression of Interferon Stimulatory Gene IFITM1 by Upregulating miR-130A
- (2012) Joydip Bhanja Chowdhury et al. JOURNAL OF VIROLOGY
- The N-Terminal Region of IFITM3 Modulates Its Antiviral Activity by Regulating IFITM3 Cellular Localization
- (2012) R. Jia et al. JOURNAL OF VIROLOGY
- IFITM Proteins Restrict Antibody-Dependent Enhancement of Dengue Virus Infection
- (2012) Ying Kai Chan et al. PLoS One
- The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A
- (2011) Karla J. Helbig et al. HEPATOLOGY
- Viperin inhibits hepatitis C virus replication by interfering with binding of NS5A to host protein hVAP-33
- (2011) S. Wang et al. JOURNAL OF GENERAL VIROLOGY
- A functional genomic screen reveals novel host genes that mediate interferon-alpha’s effects against hepatitis C virus
- (2011) Hong Zhao et al. JOURNAL OF HEPATOLOGY
- ISG56 and IFITM1 Proteins Inhibit Hepatitis C Virus Replication
- (2011) A. Raychoudhuri et al. JOURNAL OF VIROLOGY
- A diverse range of gene products are effectors of the type I interferon antiviral response
- (2011) John W. Schoggins et al. NATURE
- IFITM3 Inhibits Influenza A Virus Infection by Preventing Cytosolic Entry
- (2011) Eric M. Feeley et al. PLoS Pathogens
- Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
- (2011) I-Chueh Huang et al. PLoS Pathogens
- The Small Interferon-Induced Transmembrane Genes and Proteins
- (2010) Fredy Siegrist et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Interferon-Induced Cell Membrane Proteins, IFITM3 and Tetherin, Inhibit Vesicular Stomatitis Virus Infection via Distinct Mechanisms
- (2010) J. M. Weidner et al. JOURNAL OF VIROLOGY
- The IFITM Proteins Inhibit HIV-1 Infection
- (2010) J. Lu et al. JOURNAL OF VIROLOGY
- Identification of Five Interferon-Induced Cellular Proteins That Inhibit West Nile Virus and Dengue Virus Infections
- (2010) D. Jiang et al. JOURNAL OF VIROLOGY
- Palmitoylome profiling reveals S-palmitoylation–dependent antiviral activity of IFITM3
- (2010) Jacob S Yount et al. Nature Chemical Biology
- The SR-BI Partner PDZK1 Facilitates Hepatitis C Virus Entry
- (2010) Nicholas S. Eyre et al. PLoS Pathogens
- The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus
- (2009) Abraham L. Brass et al. CELL
- Endocytic Rab proteins are required for hepatitis C virus replication complex formation
- (2009) David Manna et al. VIROLOGY
- Principles of lysosomal membrane degradation
- (2008) Heike Schulze et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Bril: A Novel Bone-Specific Modulator of Mineralization
- (2008) Pierre Moffatt et al. JOURNAL OF BONE AND MINERAL RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started